TrademarkDir
HEALTHGEN
LIVE

Serial Number

86729223

Owner

Hsin-Yung Lin

Attorney

Justin King

First Use Date

Jun 1, 2019

Filing Date

Aug 18, 2015

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

HEALTHGEN Trademark

Serial Number: 86729223 • Registration: 5903414

HEALTHGEN is a trademark filed by Hsin-Yung Lin on August 18, 2015. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Hsin-Yung Lin (6 trademarks)

No.758
Shanghai , CN

Entity Type: 01

Trademark Details

Filing Date

August 18, 2015

Registration Date

November 5, 2019

First Use Anywhere

June 1, 2019

First Use in Commerce

June 1, 2019

Published for Opposition

July 19, 2016

Goods & Services

medical clinic services; health care; medical assistance; nursing services; medical services; aromatherapy services; physical, oxygen and hydrogen therapy services; medical equipment rental; health centers for rehabilitation and promoting self-healing; rest homes; nursing homes

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Jun 14, 2026 NAS8
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Jun 14, 2026 8.OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 14, 2026 APRE
TEAS SECTION 8 RECEIVED
Feb 23, 2026 ES8R
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 19, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 19, 2025 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Nov 19, 2025 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 19, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 19, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 19, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 19, 2025 COAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 5, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Nov 5, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 4, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 3, 2019 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Sep 13, 2019 SUPC
USE AMENDMENT FILED
Sep 11, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 11, 2019 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 16, 2019 EXRA
SOU EXTENSION 5 GRANTED
Mar 15, 2019 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 15, 2019 AITU
SOU EXTENSION 5 FILED
Mar 12, 2019 EXT5
SOU TEAS EXTENSION RECEIVED
Mar 12, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2018 EXRA
SOU EXTENSION 4 GRANTED
Sep 13, 2018 EX4G
SOU EXTENSION 4 FILED
Sep 13, 2018 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 13, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 15, 2018 EXRA
SOU EXTENSION 3 GRANTED
Mar 13, 2018 EX3G
SOU EXTENSION 3 FILED
Mar 13, 2018 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 13, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2017 EXRA
SOU EXTENSION 2 GRANTED
Sep 13, 2017 EX2G
SOU EXTENSION 2 FILED
Sep 13, 2017 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 13, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 14, 2017 EXRA
SOU EXTENSION 1 GRANTED
Mar 9, 2017 EX1G
SOU EXTENSION 1 FILED
Mar 9, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 9, 2017 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 13, 2016 NOAM
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 22, 2016 TCCA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 19, 2016 NPUB
PUBLISHED FOR OPPOSITION
Jul 19, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 29, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 9, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 8, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 7, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 7, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 7, 2015 GNRN
NON-FINAL ACTION E-MAILED
Dec 7, 2015 GNRT
NON-FINAL ACTION WRITTEN
Dec 7, 2015 CNRT
ASSIGNED TO EXAMINER
Dec 1, 2015 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Aug 22, 2015 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 21, 2015 NWOS
NEW APPLICATION ENTERED
Aug 21, 2015 NWAP

Related Trademarks

More from this Owner

HEALTHGEN

HEALTHGEN

HEALTHGEN

HEALTHGEN

HEALTHGEN

HEALTHGEN

HEALTHGEN

HEALTHGEN

HEALTHGEN

HEALTHGEN

HEALTHGEN

HEALTHGEN